Two different treatments for two kinds of arthritis
Osteoarthritis
Wear-and-tear arthritis in the hip, shoulder, hand or ankle. Cells from your own bone marrow or fat, or from donor cord, are injected into the joint. For the knee, see stem cell injections for knees.
What to expect
The procedure
Joint injections are a single outpatient visit, with a bone marrow or fat harvest first if your own cells are used. Patients describe shoulder injections as the mildest, and multi-joint or spine sessions as the most painful.[4] Nobody in our review of patient accounts was kept in overnight.[4]
When it works, and how long it lasts
Patients rarely report a change inside a month, and three to six months is the window clinics quote.[4] It is not permanent: in the hip, scores were better than baseline only at one and three months in the one study that measured them, and ankle scores worsened between one and two years.[5][6] In rheumatoid arthritis, each infusion helped for three to six months.[2]
Outside the knee, nobody has tested it against a placebo
Does it work? For hip, shoulder, hand and ankle arthritis, nobody knows: no cell product has been compared with a placebo injection at any of those joints.[1][12] For rheumatoid arthritis, disease activity falls for a few months and then drifts back.
Where it is allowed
United States. No stem cell product is FDA-approved for any kind of arthritis.[16][17]
Malaysia. Donor and lab-grown cells, including every cord product used in rheumatoid trials, must be registered before a clinic can use them.[18]
Mexico. COFEPRIS has said stem cell treatments lack authorisation.[19]
Specialists. The American College of Rheumatology recommends strongly against stem cell injections for hip arthritis. Rheumatoid arthritis guidelines do not include cell therapy.[20][21][8]
Common questions
Does it regrow cartilage?
Not shown. No controlled imaging study at the hip, shoulder, hand or ankle has found structural change.[1][22]
Can it replace my rheumatoid arthritis drugs?
No trial has tested that. One trial saw methotrexate and steroid doses fall, but not beyond a year.[3][2][23]
Will it let me avoid a hip replacement?
The study usually quoted for this was written by people employed by the company selling the treatment, and injected cells into bone rather than the joint.[24] Stem cells for hips
Questions to ask a clinic
- Which joint, and has this cell product been tested in that joint?
- How many cells will I get, and is that a stem cell count or a total cell count?
- Can I see the certificate for my batch?
- How bad is my arthritis on X-ray, and does that change your advice?
- For rheumatoid arthritis: do I keep taking my usual medicines?
- Who reviewed my scans: a doctor, or a patient adviser?
Sources
24 references
- Scott P, et al. Orthobiologic injections for hip osteoarthritis: A systematic review of clinical outcomes. Orthopedic Reviews, 2025. Link
- Wang L, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells and Development, 2013. Link
- Mesa LE, et al. Safety and efficacy of mesenchymal stem cells therapy in the treatment of rheumatoid arthritis disease: A systematic review and meta-analysis of clinical trials. PloS One, 2023. Link
- StemFinder review of first-hand patient accounts on Reddit and patient forums, 2026. Method
- Zaffagnini M, et al. Micro-fragmented adipose tissue for the treatment of hip osteoarthritis: A prospective pilot study at 1-year follow-up. Journal of Experimental Orthopaedics, 2025. Link
- Natali S, et al. The use of intra-articular injection of autologous micro-fragmented adipose tissue as pain treatment for ankle osteoarthritis: a prospective not randomized clinical study. International Orthopaedics, 2021. Link
- Natali S, et al. Efficacy and Long-Term Outcomes of Intra-Articular Autologous Micro-Fragmented Adipose Tissue in Individuals with Glenohumeral Osteoarthritis: A 36-Month Follow-Up Study. Journal of Personalized Medicine, 2023. Link
- Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. Annals of the Rheumatic Diseases, 2026. Link
- Chandrashekar S, et al. Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence. Indian Journal of Orthopaedics, 2024. Link
- Hum C, et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026. Link
- Toyserkani NM, et al. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Translational Medicine, 2017. Link
- Silveira Santiago M, et al. Clinical Response to Joint Infiltration With Bone Marrow Aspirate in Hip Osteoarthritis: A Systematic Review and Single-arm Meta-analysis. Pain Physician, 2024. Link
- Whittle SL, et al. Stem cell injections for osteoarthritis of the knee. The Cochrane Database of Systematic Reviews, 2025. Link
- Dwyer T, et al. Injection of Bone Marrow Aspirate for Glenohumeral Joint Osteoarthritis: A Pilot Randomized Control Trial. Arthroscopy, Sports Medicine, and Rehabilitation, 2021. Link
- Park EH, et al. Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study. Stem Cells Translational Medicine, 2026. Link
- U.S. Food and Drug Administration. Approved Cellular and Gene Therapy Products. U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 2026. Link
- U.S. Food and Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. 2024. Link
- National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Guidance Document and Guidelines for Registration of Cell and Gene Therapy Products (CGTPs) in Malaysia, Second Edition (September 2025). 2025. Link
- Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). La COFEPRIS suspendió clínica del D.F. que ofrecía tratamientos con Células Madre sin aval científico. Gobierno de México, COFEPRIS (press release), 2015. Link
- American College of Rheumatology. 2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand (summary). 2026. Link
- Fraenkel L, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research, 2021. Link
- Migliorini F, et al. Intra-articular injections for shoulder arthritis in adults: a systematic review. European Journal of Medical Research, 2025. Link
- Shadmanfar S, et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy, 2018. Link
- Hernigou P, et al. Intraosseous bone marrow concentrate delays total hip arthroplasty in osteoarthritis: A fifteen year matched cohort study with dose-response analysis. International Orthopaedics, 2026. Link



